The use of gene expression profiling and mutation analysis increases the cost of care for patients with carcinoma of unknown primary; Does it also improve survival?

Vinay Prasad; Andrew Oseran; Farhad Fakhrejahani

doi:10.1016/j.ejca.2015.09.006

The use of gene expression profiling and mutation analysis increases the cost of care for patients with carcinoma of unknown primary; Does it also improve survival?

Vinay Prasad, Andrew Oseran, Farhad Fakhrejahani

Knight Cancer Institute

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	159-162
Number of pages	4
Journal	European Journal of Cancer
Volume	54
DOIs	https://doi.org/10.1016/j.ejca.2015.09.006
State	Published - Feb 1 2016

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/j.ejca.2015.09.006

Cite this

@article{83d785a039184fce85a0afbc35b5d690,

title = "The use of gene expression profiling and mutation analysis increases the cost of care for patients with carcinoma of unknown primary; Does it also improve survival?",

author = "Vinay Prasad and Andrew Oseran and Farhad Fakhrejahani",

year = "2016",

month = feb,

day = "1",

doi = "10.1016/j.ejca.2015.09.006",

language = "English (US)",

volume = "54",

pages = "159--162",

journal = "European Journal of Cancer",